Emerging in the field of obesity therapy, retatrutide presents a different approach. Unlike many existing medications, retatrutide works as a twin agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and https://aadamsxkr148634.tokka-blog.com/39041763/a-innovative-retatrutide-the-glp-and-gip-receptor-agonist